Pivotal Group Expands Horizons with Precision Science Acquisition in Animal Health

Pivotal Group Acquires Precision Science



In a strategic move that highlights its commitment to growth in the animal health sector, Pivotal Group, a Phoenix-based investment firm, has announced the acquisition of Precision Science, a prominent contract manufacturer specializing in animal health. This acquisition, disclosed on November 17, 2026, marks Pivotal's first venture into the animal health industry.

Founded in 1989, Precision Science has established itself as a key player in providing contract manufacturing and product research and development services to global animal health companies. Their expertise includes the production of pharmaceuticals, medicated feed additives, and nutritional supplements, catering to an increasingly dynamic market that demands innovative solutions in animal care.

The acquisition aligns with Pivotal Group's broader strategy of nurturing businesses that demonstrate robust market positions and avenues for future growth. Recognizing Precision Science's strong foundation and its potential for market expansion, CEO Francis Najafi emphasized the excitement surrounding this opportunity. “The acquisition represents a chance to build a leading platform in animal health, beginning with supplements and pharmaceuticals,” he stated. “We are particularly drawn to the growing animal health market, coupled with Precision Science's unwavering dedication to quality and innovation.”

In response to the acquisition, Pivotal Group has commenced investments aimed at enhancing Precision Science’s manufacturing capabilities, technological advancements, and overall infrastructure. Among these initiatives is the development of a highly automated facility spanning 130,000 square feet in North Phoenix, which is already two-thirds complete. This new facility is expected to significantly boost production efficiencies, adding three manufacturing lines while also broadening capabilities to include liquids, enhancing product development and analytical capacities, and increasing storage and logistics provisions.

Bryan Vincent, CEO of Precision Science, expressed his confidence in the acquisition, noting that the trust built over years with clients will be pivotal moving forward. “Our team has laid the groundwork for Precision Science by earning our clients’ trust every day. The acquisition provides us the necessary resources to invest in people and develop our products, ensuring we meet evolving client needs,” he remarked.

The new facility will not only support evolving production demands but also create promising employment opportunities within the Phoenix area, as the company looks to expand its workforce in both manufacturing and leadership roles. Core values surrounding quality, safety, and regulatory compliance will remain a priority, underscored by the operation of an FDA-registered facility boasting an in-house laboratory and robust quality systems.

About Pivotal Group


Founded by Francis Najafi, Pivotal Group has operated as a private equity investor committed to long-term growth and investment. Their portfolio includes significant tech industry players, and they own the luxury community Promontory located in Park City, Utah.

About Precision Science


Since 1989, Precision Science has served as a contract manufacturer in the animal health space, working closely with companies and brands dedicated to advancing animal care. Through innovative practices and a focus on quality, they have positioned themselves as a trusted partner within the industry.

For more information, media inquiries can be directed to Melissa Fink at (602) 910-0624 or via email at [email protected].

Topics Business Technology)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.